Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

29.00 -1.49 (-4.89%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,933,542
Open	30.72
Bid (Size)	29.20 (600)
Ask (Size)	29.30 (1,000)
Prev. Close	30.49
Today's Range	28.75 - 31.00
52wk Range	18.92 - 43.15
Shares Outstanding	99,581,693
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Great Rotation: Russell 2000 Rockets 18% as Cooling Inflation Sparks Historic Small-Cap Surge

Today 17:31 EST

The financial landscape shifted violently this week as the long-dormant Russell 2000 index (INDEXRUSSELL:RUT) staged a breathtaking 18% rally, marking its best single-week performance in decades....

Via MarketMinute

Small Caps Roar: Russell 2000 Surges as Cooling Inflation Ignites Rate Cut Hopes

Today 11:52 EST

In a decisive shift for equity markets, the small-cap heavy Russell 2000 index outperformed its large-cap peers on Friday, February 13, 2026, as investors cheered a cooler-than-expected Consumer Price...

Via MarketMinute

Performance

YTD	-18.1%	-18.1%
1 Month	-5.5%	-5.5%
3 Month	-25.6%	-25.6%
6 Month	-27.9%	-27.9%
1 Year	-1.1%	-1.1%

More News

VKTX Stock Has Nearly 300% Wall Street Upside — Is Viking’s Oral Obesity Pill The Next Novo Nordisk-Style Breakout? ↗

February 12, 2026

Via Stocktwits

VKTX Shares Garner Retail Attention Ahead Of Q4 Earnings Report ↗

February 03, 2026

Via Stocktwits

Viking Therapeutics Stock Soars: What's Driving The Momentum? ↗

February 12, 2026

Via Benzinga

Nasdaq, S&P 500 Futures Rise, Markets Await Jobless Claims: Why NVDA, META, NKTR, NVCR, AMAT, ASTS Are On Traders' Radar Today ↗

February 12, 2026

Via Stocktwits

Viking (VKTX) Q4 2025 Earnings Call Transcript ↗

February 11, 2026

Via The Motley Fool

Dow, S&P 500 Futures Climb As House Votes To Rescind Trump Tariffs: Why VKTX, NVCR, APP, CRM, QS Are Trending After-Hours ↗

February 11, 2026

Via Stocktwits

VKTX Stock Rallies After Hours On Optimism Around Company’s Obesity Pipeline ↗

February 11, 2026

Via Stocktwits

Viking Therapeutics: The Under‑the‑Radar GLP‑1 Contender Growth Hunters Can't Ignore ↗

February 11, 2026

Via The Motley Fool

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗

February 10, 2026

Via The Motley Fool

Could Eli Lilly Turn Today's GLP‑1 Obesity Boom Into Multi‑Decade, Millionaire‑Maker Gains? ↗

February 10, 2026

Via The Motley Fool

3 Things Investors Need to Know About the Healthcare Sector in 2026 ↗

February 07, 2026

Via The Motley Fool

Eli Lilly Projects Record $80B-$83B Revenue for 2026 as Metabolic Franchise Decouples from Competition

February 06, 2026

Via MarketMinute

The Great GLP-1 Divergence: Eli Lilly Surges Toward Trillion-Dollar Dominance as Novo Nordisk Falters on U.S. Price Cuts

February 05, 2026

Via MarketMinute

The Smartest Growth Stock to Buy With $30 Right Now ↗

February 03, 2026

Via The Motley Fool

2 Biotech Stocks Set to Rebound in 2026 ↗

January 27, 2026

Via The Motley Fool

Eli Lilly or Viking Therapeutics: Which Stock Is More Likely to be a Millionaire-Maker? ↗

January 26, 2026

Via The Motley Fool

3 Growth Stocks to Invest $1,000 in Right Now ↗

January 24, 2026

Via The Motley Fool

The Best Stocks to Invest $40 in to Start the New Year Off Right ↗

January 24, 2026

Via The Motley Fool

Viking Therapeutics (VKTX) 2026 Deep Dive: Challenging the Obesity Duopoly

January 23, 2026

Via Finterra

Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 ↗

January 23, 2026

Via The Motley Fool

The Trillion-Dollar Heavyweight: Eli Lilly Surge Signals Unrivaled Dominance in the GLP-1 Era

January 22, 2026

Via MarketMinute

2 Bargain Stocks You Can Buy for Less Than $100 Right Now ↗

January 21, 2026

Via The Motley Fool

1 Stock That Could Soar by 175%, According to Wall Street ↗

January 21, 2026

Via The Motley Fool

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?

Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Viking Therapeutics, Inc. - Common Stock trade on?

Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?

The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market

What is the current price of Viking Therapeutics, Inc. - Common Stock?

The current price of Viking Therapeutics, Inc. - Common Stock is 29.00

When was Viking Therapeutics, Inc. - Common Stock last traded?

The last trade of Viking Therapeutics, Inc. - Common Stock was at 02/13/26 04:00 PM ET

What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?

The market capitalization of Viking Therapeutics, Inc. - Common Stock is 2.89B

How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?

Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.